3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
9
Completed
3
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
50
Carcinoma, Non-Small-Cell Lung
39
Carcinoma, Renal Cell
28
Carcinoma, Hepatocellular
18
Neoplasm Metastasis
16
Neoplasms
15
Colorectal Neoplasms
15
Stomach Neoplasms
13
Lung Neoplasms
13
Adenocarcinoma Of Esophagus
11
Squamous Cell Carcinoma of Head and Neck
10
Carcinoma, Transitional Cell
8
Brain Neoplasms
8
Hodgkin Disease
7
Skin Neoplasms
6
Sarcoma
6
Esophageal Neoplasms
6
Clear-cell metastatic renal cell carcinoma
6
Triple Negative Breast Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Kidney Neoplasms
5
Carcinoma, Merkel Cell
5
Uveal Melanoma
4
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Recurrence
4
Neuroendocrine Tumors
4
Nasopharyngeal Carcinoma
4
Mesothelioma
4
Interventions
Capecitabine
29
Oxaliplatin
28
Fluorouracil
16
Radiotherapy
15
Drug Therapy
11
Leucovorin
10
Bevacizumab
10
Surgical Procedures, Operative
9
Chemoradiotherapy
8
Radiation
7
sintilimab
6
Consolidation Chemotherapy
6
tislelizumab
5
spartalizumab
5
Specimen Handling
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
XELOX
4
Neoadjuvant Therapy
4
Endoscopy
4
Cetuximab
4
Biopsy
4
toripalimab
3
pembrolizumab
3
irinotecan sucrosofate
3
X-Rays
3
Radiotherapy, Intensity-Modulated
3
Proctectomy
3
Mastectomy, Segmental
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Rectal Neoplasms
×
Nivolumab
×
Clear all
NCT05732389
2025-08-07
RESET-R
Odense University Hospital
Phase 2
Recruiting
39 enrolled